284 related articles for article (PubMed ID: 36251040)
1. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X
Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
Shang X; E FF; Guo KL; Li YF; Zhao HL; Wang Y; Chen N; Nian T; Yang CQ; Yang KH; Li XX
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745212
[TBL] [Abstract][Full Text] [Related]
4. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
6. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
Liu N; Li J; Wang Y; Zhang S
J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
8. Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
Yin X; Li S; Ouyang M; Ou R; Chen Z; Wei S; Huang H; Liu D
Ann Palliat Med; 2022 Dec; 11(12):3785-3793. PubMed ID: 36510459
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC
Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528
[TBL] [Abstract][Full Text] [Related]
10. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
Xu HL; Zou LL; Chen MB; Wang H; Shen WM; Zheng QH; Cui WY
PLoS One; 2021; 16(8):e0255160. PubMed ID: 34358238
[TBL] [Abstract][Full Text] [Related]
12. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Xie P; Luo M; Deng X; Fan J; Xiong L
Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
14. Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis.
Guo J; Xing X; Wu J; Zhang H; Yun Y; Qin Z; He Q
Neural Plast; 2020; 2020():8892184. PubMed ID: 33299403
[No Abstract] [Full Text] [Related]
15. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Zhang T; Zhang C; Zhang J; Sun F; Duan L
Front Cell Infect Microbiol; 2022; 12():859967. PubMed ID: 35433498
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and dose response of
Martoni CJ; Srivastava S; Damholt A; Leyer GJ
World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
[TBL] [Abstract][Full Text] [Related]
18. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
Hu Y; Tao L; Lyu B
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ
Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
